SCHEMBL26612423

SCHEMBL26612423

CCCCC/C=C\CCOC(=O)CCCCC(=O)OCC/C=C\CCCCC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.69
MAPT P10636 3/20 0.67
ALDH1A1 P00352 1/20 0.67
THRB P10828 1/20 0.67
CNR1 P21554 1/20 0.67
DGKA P23743 2/20 0.66
PRKCE Q02156 1/20 0.57
PRKCQ Q04759 1/20 0.57
PRKCD Q05655 1/20 0.57
PRKCA P17252 1/20 0.57
EPHX2 P34913 1/20 0.57
TERT O14746 3/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2C19 P33261 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
FAAH O00519 2/20 0.56
PTPN1 P18031 2/20 0.56
PPARG P37231 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29119058 1.00 MGLL (0.69) MGLLMAPTALDH1A1THRBCNR1
SCHEMBL30052689 0.98 DGKA (0.69) MGLLMAPTALDH1A1THRBCNR1
SCHEMBL15027047 0.98 DGKA (0.69) MGLLMAPTALDH1A1THRBCNR1
SCHEMBL30763829 0.98 DGKA (0.69) MGLLMAPTALDH1A1THRBCNR1
SCHEMBL30763760 0.98 DGKA (0.69) MGLLMAPTALDH1A1THRBCNR1
SCHEMBL30592517 0.98 DGKA (0.69) MGLLMAPTALDH1A1THRBCNR1
SCHEMBL28956069 0.96 DGKA (0.66) MGLLMAPTALDH1A1THRBCNR1
SCHEMBL10086074 0.95 MGLL (0.77) MGLLMAPTALDH1A1THRBCNR1
SCHEMBL28365733 0.95 DGKA (0.65) MGLLMAPTALDH1A1THRBCNR1
SCHEMBL25283280 0.93 PPARG (0.69) MAPTALDH1A1TERTCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348359-A1 IONIZABLE LIPIDS FOR NANOMATERIALS BEAM THERAPEUTICS INC. (US) 2023-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348359-A1 IONIZABLE LIPIDS FOR NANOMATERIALS PHOSPHO1, SGMS2, SGMS1 MGLL 22/4885MAPT 2703/4885ALDH1A1 3850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.